PT141

PT141 (Bremelanotide) is a melanocortin receptor agonist that acts centrally on the nervous system to enhance sexual desire and function in both men and women. Unlike conventional treatments, it works on the brain rather than the vascular system.

Key Benefits

• Increases sexual desire and arousal in men and women
• Centrally acting mechanism via melanocortin receptors
• Effective for both psychological and physiological causes
• Fast onset of action (30–60 minutes)
• Supports healthy sexual function and satisfaction
• Used in research for hypoactive sexual desire disorder

Recommended Use

Typical dosage is 1–2mg via subcutaneous injection 30–60 minutes before activity. Start with lowest effective dose. Consult with a healthcare professional before use.